Sapylin 在腔镜甲状腺癌手术中的疗效:双盲随机对照试验
结果显示 Sapylin 组术后第 1 天、第 2 天及总引流量均显著降低,但炎症标志物短暂升高且声音嘶哑发生率显著增加(16 例 vs 6 例,P=0.015),所有声音嘶哑均为暂时性并可完全恢复。
要点
- Sapylin 可显著减少腔镜甲状腺癌根治术后引流量。
- Sapylin 组炎症标志物短暂升高但迅速恢复正常。
- Sapylin 组暂时性声音嘶哑发生率更高,但无永久性声带麻痹。
核心结论
- Sapylin 可显著减少腔镜甲状腺癌根治术后引流量,但伴随全身炎症反应和暂时性声音嘶哑风险增加,应用需权衡利弊。
主要发现
- Sapylin 组术后第 1 天引流量显著低于对照组(P=0.026)。
- Sapylin 组术后第 2 天引流量显著低于对照组(P=0.014)。
- Sapylin 组总引流量显著低于对照组(P=0.009)。
- Sapylin 组炎症标志物短暂升高(P<0.01)但迅速恢复正常。
- Sapylin 组声音嘶哑发生率显著高于对照组(16 例 vs 6 例,P=0.015),均为暂时性且声带活动完全恢复,无永久性声带麻痹。
临床怎么用
- 在腔镜甲状腺癌手术中可考虑使用 Sapylin 减少术后引流量,但需警惕暂时性声音嘶哑和炎症反应,谨慎权衡获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative exudation after thyroidectomy can compromise healing. Although Sapylin (Group A Streptococcus pyogenes) promotes wound repair, its efficacy and safety in endoscopic thyroid cancer surgery remain unclear. This randomized controlled trial evaluated Sapylin's impact on postoperative drainage and complications. METHODS: Ninety-two patients were randomized (1:1) to receive 10 KE Sapylin in 20 ml saline (treatment group) or saline alone (control group) via the drainage tube. Endpoints included drainage volume, inflammatory markers, and assessment of short-term and long-term complications, specifically vocal function. RESULTS: The treatment group showed significantly lower drainage volumes on Day 1 (P = 0.026), Day 2 (P = 0.014), and in total (P = 0.009). Inflammatory markers were transiently elevated in the treatment group (P < 0.01) but normalized rapidly. Notably, the incidence of hoarseness was significantly higher in the treatment group (16 vs. 6 cases, P = 0.015). Crucially, long-term follow-up confirmed that all cases of hoarseness were transient. All affected patients achieved complete recovery of vocal cord mobility, and no cases of permanent vocal cord paralysis were observed. CONCLUSION: Sapylin significantly reduces postoperative drainage volume following endoscopic radical thyroidectomy. However, its application is associated with a systemic inflammatory response and an increased risk of transient postoperative hoarseness. Although this nerve dysfunction is reversible, given the potential for neural irritation, its application should be restricted or approached with extreme caution, carefully weighing the benefits of drainage reduction against the risk of transient hoarseness. TRAIL REGISTRATION: This study was registered with the Chinese Clinical Trial Registry (accessible by logging in at https://www.chictr.org.cn/ ), registration number ChiCTR2500103444.
引用
- Chen Y, Wang S, Bin B, et al. Efficacy of Sapylin in endoscopic thyroid cancer surgery: a double-blind, randomized, controlled trial. Surg Endosc. 2026. PMID: 42377525. doi:10.1007/s00464-026-12762-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。